Cargando…

Duration biased distribution of clinical and immunological phenotypes in active SLE

INTRODUCTION: This study is aimed to map the clinical and immunological features of active lupus patients with different disease duration. METHODS: For clinical phenotype analysis, we enriched eligible medical records with active SLE (SLEDAI-2k≥8) from the Renji Lupus registry, a single-center datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Qingran, Liu, Bei, Yang, Minjie, Li, Qianqian, Wang, Jieying, Li, Ting, Lu, Liangjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794596/
https://www.ncbi.nlm.nih.gov/pubmed/36591231
http://dx.doi.org/10.3389/fimmu.2022.1044184
_version_ 1784860072639201280
author Yan, Qingran
Liu, Bei
Yang, Minjie
Li, Qianqian
Wang, Jieying
Li, Ting
Lu, Liangjing
author_facet Yan, Qingran
Liu, Bei
Yang, Minjie
Li, Qianqian
Wang, Jieying
Li, Ting
Lu, Liangjing
author_sort Yan, Qingran
collection PubMed
description INTRODUCTION: This study is aimed to map the clinical and immunological features of active lupus patients with different disease duration. METHODS: For clinical phenotype analysis, we enriched eligible medical records with active SLE (SLEDAI-2k≥8) from the Renji Lupus registry, a single-center database of hospitalized SLE patients with standard care, which covered national-wide patients. Patients with repeated hospitalization records in this enrichment were analyzed longitudinally as validation for the cross-sectional study above. RESULTS: We enriched a total of 1313 eligible records on active SLE (SLEDAI-2k≥8) for cross-sectional analysis. Stratified into four groups by a 5-year interval of disease duration, these active SLE patients showed a significantly shifting clinical phenotype along with the duration (ascending nephritis, pulmonary hypertension and descending fever, cutaneous symptoms, arthritis, and neuropsychiatric manifestations), especially in stratifications with disease onset age ≤ 45 years old. A longitudinal analysis of 55 patients with repeated hospitalizations for active lupus showed a similar trend. In the cross-sectional study of 222 records with full information on serology and lymphocyte subsets, peripheral B cell proportion, anti-dsDNA antibody, and serum IgG/IgM negatively correlated with duration, while CD8+ T cell proportion was positively correlated (P values, 0.029-4.8×10(-17)), which were supported by the sensitivity analysis in patient subgroups according to disease onset age and recent treatment. Multivariate linear regression identified duration as the only significant associator with both B cell and CD8+ T cell proportion (P values, 8.9×10(-8) and 7.6×10(-5), respectively). These duration biased immune phenotypes were highly consistent with the longitudinal observation in 14 patients with repeated hospitalizations. CONCLUSIONS: Both clinical and immunological features of active SLE are significantly duration biased distributed, which merits further investigations in the evolution of SLE pathogenesis.
format Online
Article
Text
id pubmed-9794596
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97945962022-12-29 Duration biased distribution of clinical and immunological phenotypes in active SLE Yan, Qingran Liu, Bei Yang, Minjie Li, Qianqian Wang, Jieying Li, Ting Lu, Liangjing Front Immunol Immunology INTRODUCTION: This study is aimed to map the clinical and immunological features of active lupus patients with different disease duration. METHODS: For clinical phenotype analysis, we enriched eligible medical records with active SLE (SLEDAI-2k≥8) from the Renji Lupus registry, a single-center database of hospitalized SLE patients with standard care, which covered national-wide patients. Patients with repeated hospitalization records in this enrichment were analyzed longitudinally as validation for the cross-sectional study above. RESULTS: We enriched a total of 1313 eligible records on active SLE (SLEDAI-2k≥8) for cross-sectional analysis. Stratified into four groups by a 5-year interval of disease duration, these active SLE patients showed a significantly shifting clinical phenotype along with the duration (ascending nephritis, pulmonary hypertension and descending fever, cutaneous symptoms, arthritis, and neuropsychiatric manifestations), especially in stratifications with disease onset age ≤ 45 years old. A longitudinal analysis of 55 patients with repeated hospitalizations for active lupus showed a similar trend. In the cross-sectional study of 222 records with full information on serology and lymphocyte subsets, peripheral B cell proportion, anti-dsDNA antibody, and serum IgG/IgM negatively correlated with duration, while CD8+ T cell proportion was positively correlated (P values, 0.029-4.8×10(-17)), which were supported by the sensitivity analysis in patient subgroups according to disease onset age and recent treatment. Multivariate linear regression identified duration as the only significant associator with both B cell and CD8+ T cell proportion (P values, 8.9×10(-8) and 7.6×10(-5), respectively). These duration biased immune phenotypes were highly consistent with the longitudinal observation in 14 patients with repeated hospitalizations. CONCLUSIONS: Both clinical and immunological features of active SLE are significantly duration biased distributed, which merits further investigations in the evolution of SLE pathogenesis. Frontiers Media S.A. 2022-12-14 /pmc/articles/PMC9794596/ /pubmed/36591231 http://dx.doi.org/10.3389/fimmu.2022.1044184 Text en Copyright © 2022 Yan, Liu, Yang, Li, Wang, Li and Lu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yan, Qingran
Liu, Bei
Yang, Minjie
Li, Qianqian
Wang, Jieying
Li, Ting
Lu, Liangjing
Duration biased distribution of clinical and immunological phenotypes in active SLE
title Duration biased distribution of clinical and immunological phenotypes in active SLE
title_full Duration biased distribution of clinical and immunological phenotypes in active SLE
title_fullStr Duration biased distribution of clinical and immunological phenotypes in active SLE
title_full_unstemmed Duration biased distribution of clinical and immunological phenotypes in active SLE
title_short Duration biased distribution of clinical and immunological phenotypes in active SLE
title_sort duration biased distribution of clinical and immunological phenotypes in active sle
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794596/
https://www.ncbi.nlm.nih.gov/pubmed/36591231
http://dx.doi.org/10.3389/fimmu.2022.1044184
work_keys_str_mv AT yanqingran durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle
AT liubei durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle
AT yangminjie durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle
AT liqianqian durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle
AT wangjieying durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle
AT liting durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle
AT luliangjing durationbiaseddistributionofclinicalandimmunologicalphenotypesinactivesle